Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-25-004833

Chief Accounting Officer sold 332 shares at $0.44 ($146)

From the SEC's structured data for this filing

Trades in this filing

Hagen Brett R · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-01-10 Sale : show line 1 in the form −332 $0.44 $146 68,174 D
Open-market sales · 332 sh · avg $0.44 · $146
Loading xslF345X05/ownership.xml…